<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DB3BCEAD-7AF1-453F-B56E-8CEA2199DA0F"><gtr:id>DB3BCEAD-7AF1-453F-B56E-8CEA2199DA0F</gtr:id><gtr:firstName>Venugopal</gtr:firstName><gtr:surname>Nair</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FG001642%2F1"><gtr:id>A4EA9E4F-CE1D-40CF-A5BB-1189721C1551</gtr:id><gtr:title>The role of the Marek's disease virus (MDV) Meq oncoprotein in the pathogenesis of Marek's disease and the development of MDV vaccine strains</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G001642/1</gtr:grantReference><gtr:abstractText>Marek's disease (MD) is a common disease of chickens involving paralysis and commonly death from the growth of highly malignant T lymphomas (cancers of white blood cells). Unusual for a cancer, MD is caused by a transmissible agent, Marek's disease virus (MDV). MDV is very contagious and is a major threat to the poultry industry worldwide, but it can be controlled by vaccination. More than 5 billion vaccine doses a year are used in an attempt to control the disease. However, there is a continuous evolution of the virus towards greater virulence and consequently new vaccines are required. The mechanisms by which the virus gains virulence and produces tumours remain very poorly understood. Similarly, the factors that determine an effective vaccine strain remain unclear. With financial support from the BBSRC, we have been studying a protein called Meq that is made by MDV in the cancer cells. Our recent results have demonstrated unequivocally that this protein is absolutely essential for the induction of tumours by MDV (it is therefore known as an oncoprotein). Moreover it has been possible to identify specific protein:protein interactions involving Meq that are necessary for its function as an oncoprotein. We have made various defined mutations in the Meq-encoding gene that produce attenuated (non-pathogenic) MDV that we showed can be used as vaccines. This is a proposal to build on this work in order to determine the precise contribution that Meq makes to the development of Marek's disease in its various pathological manifestations / including malignant and paralytic forms / and to try and understand better what constitutes an effective vaccine strain of MDV.</gtr:abstractText><gtr:technicalSummary>Recently, we identified a binding motif (20PLDLS24) for the cell co-repressor CtBP in the Meq nuclear oncoprotein encoded by MDV. This is similar to binding sites in oncoproteins EBNA3A and EBNA3C of Epstein-Barr virus (EBV). MDV is a lymphotropic alphaherpesvirus of chickens that / like EBV / can induce malignant disease. The T cell hyperplasia it produces is responsible for many of the symptoms of the fatal disease of chickens known as Marek's disease (MD). By constructing mutants of Meq in a bacterial artificial chromosome (BAC) clone of MDV, we showed that this interaction between Meq and CtBP is essential for oncogenicity in chickens. This genetically engineered, attenuated strain of MDV very effectively protects chicks from further challenge with very virulent strains of MDV and has potential as a vaccine. In order to determine the role of the leucine zipper in Meq and of Meq dimerisation in lymphomagenesis, specific point mutations were engineered into the highly oncogenic RB-1B-BAC to produce virus completely lacking a functional Meq leucine zipper and virus encoding Meq that cannot homodimerize, but can still bind to c-Jun. Both of these mutant viruses are non-oncogenic. We conclude that the leucine zipper is necessary for the oncogenic activity of Meq and/or the establishment of long-term MDV latency in T cells. Moreover, it appears that the ability to form repressive homodimeric Meq complexes is an absolute requirement for the cancer associated with virulent MDV. We will determine the roles of Meq in non-malignant, but rapidly fatal CNS-associated MD. We will identify specific target chicken genes that are regulated by Meq and establish the roles of interacting protein partners of Meq. It should also be possible to establish what role Meq plays in viral latency and replication in vivo and explore the molecular characteristics of MDV that constitute an effective vaccine for the prevention of MD.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-17</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-04-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>412282</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We showed that transformed lymphoblastoid cell lines induce de novo tumours and vaccination with CVI988 can prevent tumours.
We also showed that MD tumour cell lines are composed of monoclonal T cell populations and large tumour clones can be identified in blood of MDV infected birds even before the tumours can be visualised.</gtr:description><gtr:exploitationPathways>the findings from the project can be examined with application in other virus-induced neoplastic diseases</gtr:exploitationPathways><gtr:id>71798BF5-608A-404B-94D4-3AABE51E7379</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B09929D-0375-4B90-B8D6-6226306924AB"><gtr:id>3B09929D-0375-4B90-B8D6-6226306924AB</gtr:id><gtr:title>Mutagenesis of the repeat regions of herpesviruses cloned as bacterial artificial chromosomes.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A430C99F-1698-44BB-AE92-4E8A0B3C3A9B"><gtr:id>A430C99F-1698-44BB-AE92-4E8A0B3C3A9B</gtr:id><gtr:title>Systems analysis of immune responses in Marek's disease virus-infected chickens identifies a gene involved in susceptibility and highlights a possible novel pathogenicity mechanism.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d46dc28a53e3e7dbb98c412f1ff766a2"><gtr:id>d46dc28a53e3e7dbb98c412f1ff766a2</gtr:id><gtr:otherNames>Smith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F38CED0-49C2-4464-A369-EEC3348522CE"><gtr:id>6F38CED0-49C2-4464-A369-EEC3348522CE</gtr:id><gtr:title>Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a67ad19c21b313e31121fda50d7e8b0"><gtr:id>3a67ad19c21b313e31121fda50d7e8b0</gtr:id><gtr:otherNames>Brown AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D05A2507-19C5-4A35-A0FC-5DFE4E0323BB"><gtr:id>D05A2507-19C5-4A35-A0FC-5DFE4E0323BB</gtr:id><gtr:title>Regional and global changes in TCRalphabeta T cell repertoires in the gut are dependent upon the complexity of the enteric microflora.</gtr:title><gtr:parentPublicationTitle>Developmental and comparative immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dedddcce92d8c9226e2936889c9999a7"><gtr:id>dedddcce92d8c9226e2936889c9999a7</gtr:id><gtr:otherNames>Mwangi WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0145-305X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84115EC9-D153-4108-AE70-DC278582BDEC"><gtr:id>84115EC9-D153-4108-AE70-DC278582BDEC</gtr:id><gtr:title>Analysis of the early immune response to infection by infectious bursal disease virus in chickens differing in their resistance to the disease.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d46dc28a53e3e7dbb98c412f1ff766a2"><gtr:id>d46dc28a53e3e7dbb98c412f1ff766a2</gtr:id><gtr:otherNames>Smith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B9A3DFFF-4835-4CA4-AA90-D4C6DB21882E"><gtr:id>B9A3DFFF-4835-4CA4-AA90-D4C6DB21882E</gtr:id><gtr:title>Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3a67ad19c21b313e31121fda50d7e8b0"><gtr:id>3a67ad19c21b313e31121fda50d7e8b0</gtr:id><gtr:otherNames>Brown AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C489409F-2CBD-4CB9-9ED8-908807457BAB"><gtr:id>C489409F-2CBD-4CB9-9ED8-908807457BAB</gtr:id><gtr:title>Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D3F9267A-7811-4BC6-BE2B-130B40442648"><gtr:id>D3F9267A-7811-4BC6-BE2B-130B40442648</gtr:id><gtr:title>Epigenetic regulation of the long repeats of Marek's Disease Virus (MDV) associated with latent and lytic expression profiles</gtr:title><gtr:parentPublicationTitle>5th International Workshop on the Molecular Pathogenesis of Marek's Disease Virus, University of Georgia, Athens, USA, 17-20 October 2010</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ff5c71c07b14727cc3d86a39f46a326"><gtr:id>7ff5c71c07b14727cc3d86a39f46a326</gtr:id><gtr:otherNames>Brown A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC7246FA-17E8-4EB2-B194-D69AC13C1CBB"><gtr:id>DC7246FA-17E8-4EB2-B194-D69AC13C1CBB</gtr:id><gtr:title>Interaction of Marek's disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/673680106ade3187f249d2a683028495"><gtr:id>673680106ade3187f249d2a683028495</gtr:id><gtr:otherNames>Zhao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3C9DD8E-B83D-4B00-A35D-89C8F88945D6"><gtr:id>A3C9DD8E-B83D-4B00-A35D-89C8F88945D6</gtr:id><gtr:title>Rate of natural transmission of Marek's disease virus (MDV) to susceptible chickens in the post-challenge period: effect of vaccination with HVT and association with MDV genome count in air.</gtr:title><gtr:parentPublicationTitle>Zootecnica International</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a888b58640251c5387f839a997e66b55"><gtr:id>a888b58640251c5387f839a997e66b55</gtr:id><gtr:otherNames>Crabb JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB3067A3-3CC2-4E58-B650-8D20E334FAFC"><gtr:id>DB3067A3-3CC2-4E58-B650-8D20E334FAFC</gtr:id><gtr:title>Functional evaluation of the role of reticuloendotheliosis virus long terminal repeat (LTR) integrated into the genome of a field strain of Marek's disease virus.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3442a6e204d310a36d4dc43c6a818d44"><gtr:id>3442a6e204d310a36d4dc43c6a818d44</gtr:id><gtr:otherNames>Sun AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1DCBE51-3E4B-41CC-A73D-6D82F890B837"><gtr:id>A1DCBE51-3E4B-41CC-A73D-6D82F890B837</gtr:id><gtr:title>Induction of lymphomas by inoculation of Marek's disease virus-derived lymphoblastoid cell lines: prevention by CVI988 vaccination.</gtr:title><gtr:parentPublicationTitle>Avian pathology : journal of the W.V.P.A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dedddcce92d8c9226e2936889c9999a7"><gtr:id>dedddcce92d8c9226e2936889c9999a7</gtr:id><gtr:otherNames>Mwangi WN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0307-9457</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D82AED67-EA28-410D-BE7E-BCDC952728BE"><gtr:id>D82AED67-EA28-410D-BE7E-BCDC952728BE</gtr:id><gtr:title>Genotypic characterization of two bacterial artificial chromosome clones derived from a single DNA source of the very virulent gallid herpesvirus-2 strain C12/130.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/590821c637ac66ae78a9b478c1242af2"><gtr:id>590821c637ac66ae78a9b478c1242af2</gtr:id><gtr:otherNames>Spatz SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/08D915DA-781D-493D-9EED-7D4474F1C6DD"><gtr:id>08D915DA-781D-493D-9EED-7D4474F1C6DD</gtr:id><gtr:title>Differential quantification of cloned CVI988 vaccine strain and virulent RB-1B strain of Marek's disease viruses in chicken tissues, using real-time PCR.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ae640df89a020942516dc56e726e29a"><gtr:id>7ae640df89a020942516dc56e726e29a</gtr:id><gtr:otherNames>Baigent SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G001642/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>